Opening Plenary: Enabling Access Through Innovation – Cell and Gene Therapy in 2023 and Beyond

18 Jan 2023
Manufacturing Advanced Therapies Track
Discovery Life Sciences

09:00am Chair Introduction

Jörg Shneider, Associate Principal Consultant, Biopharma Excellence


09:05am Presentation: Top Ten Events of 2022

Susan Nichols, Chief Business Officer, ViroCell Biologics


09:20am Presentation: Update On The Research Landscape for Cell and Gene Therapies

David Barrett, Chief Executive Officer, American Society for Gene and Cell Therapies 


09:35am Presentation: The Manufacturing Landscape for Cell and Gene Therapy

Cynthia Pussinen, Chief Technology Officer, Spark Therapeutics


09:50am Presentation: The CDMO and Technology Innovation Transforming Cell and Gene Therapy

Dominic Clarke, Chief Technical Officer, Cell and Gene Therapy, Discovery Life Sciences


10:05pm Closing Panel with Q&A: How Are We Enabling Innovation for Cell and Gene Therapies?

With all session participants


Cynthia Pussinen
Chief Technical Officer
Spark Therapeutics
David Barrett
Chief Executive Officer
Mayo Clinic
Dominic Clarke
Chief Technical Officer, Cell and Gene Therapy
Discovery Life Sciences
Jörg Schneider
Associate Director & Associate Principal Consultant
BioPharma Excellence
Susan B. Nichols
Chief Business Officer
ViroCell Biologics